UCB News

@ucb_news

A global biopharma company focusing on creating value for people living with neurology and immunology diseases. We are inspired by patients, driven by science.

Headquarters, Brussels
Vrijeme pridruživanja: srpanj 2010.

Medijski sadržaj

  1. prije 18 sati

    The second Monday of February is International where people come together to highlight problems faced by the 65 million people living with worldwide. Yet despite the high prevalence, many patients will not receive treatment

  2. 4. velj

    UCB scientists have discovered the first ‘small molecules’ that could inhibit TNF – a key protein involved in inflammatory diseases, including rheumatoid arthritis

  3. 3. velj
  4. 28. sij
  5. 24. sij

    The drug development process can take 10-15 years from early-stage discovery to marketing authorization. has the potential to accelerate this process and make it significantly more efficient. Find out more

  6. 22. sij

    that women who experience a first fragility fracture are at significant risk for experiencing subsequent fractures, particularly in the 2 years after the fracture? Read a summary of the findings published in the Journal of Bone and Mineral Research

  7. 10. sij

    Based on a recent UCB survey, almost 1 in 5 patients living with reported having to reduce their working hours, and one in 8 said the condition meant they had to give up work completely.

  8. 7. sij
  9. 30. pro 2019.

    We’re counting down to 2020 - not just a new day or a new year but a new decade! Stay tuned for news on the 2020’s promising innovations

  10. 23. pro 2019.

    It’s a special time of the year all over the world. We want to show our appreciation to everyone who has helped us delivering new solutions to patients

  11. 20. pro 2019.
  12. 20. pro 2019.

    There are approximately 5 million people living with rheumatoid arthritis in China, women are especially impacted. We are proud to support these patients by providing new treatment options. Learn more

  13. 18. pro 2019.
  14. 16. pro 2019.
  15. 12. pro 2019.
  16. 10. pro 2019.

    is forecast to affect 12.9 million people by 2040. Read how could accelerate the development of new therapeutic options for people living with PD

  17. 10. pro 2019.
  18. 10. pro 2019.

    At this year’s , we’re proud to announce our new which helps diagnose and grade vertebral using . Find out more here:

  19. 9. pro 2019.

    One vertebral fracture occurs every 22 seconds worldwide in men and women over age 50! Our novel aims to detect these which have a detrimental impact on daily living. Learn more here:

  20. 8. pro 2019.

    For some people, can be an ‘invisible disease’ with symptoms that can't always be seen and can come and go. Look out for these symptoms.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·